About InterShunt Technologies
InterShunt Technologies is a company based in United States founded in 2015 by Gil Vardi.. InterShunt Technologies has raised $26.55 million across 3 funding rounds from investors including Gener8tor, Solas BioVentures and Arsenal Capital Management. InterShunt Technologies offers products and services including PAS-C. InterShunt Technologies operates in a competitive market with competitors including Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others.
- Headquarter Louisiana, United States
- Founders Gil Vardi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intershunt Technologies, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26.55 M (USD)
in 3 rounds
-
Latest Funding Round
$23.42 M (USD), Series B
Aug 09, 2024
-
Investors
Gener8tor
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InterShunt Technologies
InterShunt Technologies offers a comprehensive portfolio of products and services, including PAS-C. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Catheter system to create atrial shunts for heart failure relief.
Unlock access to complete
Unlock access to complete
Funding Insights of InterShunt Technologies
InterShunt Technologies has successfully raised a total of $26.55M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $23.42 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $23.4M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series B - InterShunt Technologies | Valuation |
investors |
|
| Jan, 2021 | Amount | Series A - InterShunt Technologies | Valuation | Solas BioVentures | |
| Jul, 2018 | Amount | Seed - InterShunt Technologies | Valuation | Gener8tor |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InterShunt Technologies
InterShunt Technologies has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Gener8tor, Solas BioVentures and Arsenal Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital and acceleration are provided to life science startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InterShunt Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InterShunt Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intershunt Technologies Comparisons
Competitors of InterShunt Technologies
InterShunt Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, Lifetech Scientific Corporation, HDL Therapeutics, Supira Medical and Transvascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of neuroprotection devices for carotid artery disease
|
|
| domain | founded_year | HQ Location |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| domain | founded_year | HQ Location |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| domain | founded_year | HQ Location |
A TransAccess Catheter System that is used to deliver cells to damaged portions of the heart
|
|
| domain | founded_year | HQ Location |
Catheter ablation treatments for atrial fibrillation are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intershunt Technologies
Frequently Asked Questions about InterShunt Technologies
When was InterShunt Technologies founded?
InterShunt Technologies was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is InterShunt Technologies located?
InterShunt Technologies is headquartered in United States. It is registered at Louisiana, United States.
Who is the current CEO of InterShunt Technologies?
Harlee Sorkin is the current CEO of InterShunt Technologies.
Is InterShunt Technologies a funded company?
InterShunt Technologies is a funded company, having raised a total of $26.55M across 3 funding rounds to date.
What does InterShunt Technologies do?
InterShunt Technologies was founded in 2015 and is based in Louisiana, United States. Focus is placed on the medical device sector, where cardiac catheters are developed for treating cardiac conditions. Operations center on the creation of intershunt atrial septostomy catheters, which facilitate precise tissue capture, cutting, and excision from the interatrial septum. This approach aids in lowering elevated left atrial pressure. The domain intershunt.com is utilized for online presence.
Who are the top competitors of InterShunt Technologies?
InterShunt Technologies's top competitors include Silk Road Medical, Lifetech Scientific Corporation and Supira Medical.
What products or services does InterShunt Technologies offer?
InterShunt Technologies offers PAS-C.
Who are InterShunt Technologies's investors?
InterShunt Technologies has 4 investors. Key investors include Gener8tor, Solas BioVentures, Arsenal Capital Management, and BioGenerator Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.